September 20, 2016 Sophia Vida
Biotech & Pharma

Allergan (AGN) May Pay A Lot Of Money For This Company

Pharmaeutical titan, Allergan, is acquiring Tobira Therapuetics in a deal that’s initially for $28.35 per share. According to a statement however from Allergan, the deal could grow far more expensive. Tobira is developing two drugs to treat NASH disease, a silent and often common liver disease. According to the Allergan statement, NASH is a buildup … Continue reading “Allergan (AGN) May Pay A Lot Of Money For This Company”